adsilico
A University of Leeds spinout whose Virtual Chimera platform builds virtual hearts and blood vessels from anonymised clinical scans with generative AI, then runs physics simulations of how a heart valve, stent or other implant behaves in each, across a population varied by age, sex, ethnicity, body size and disease.
Money and evidence
No research by this company is on the record yet.
Rounds and research, on one timeline
- 2026-10-26Series ARound
£10M≈ $13.3M
For: further develop the virtual heart models, expand into neurovascular devices such as flow diverters for brain aneurysms, and grow the team from 14 to 34
Models and platformHiring
Announced by Northern Gritstone, which says it put in £5M of the £10M and lists PXN Ventures and Parkwalk as investors; that PXN led and the other two are existing investors is Tech.eu's account (https://tech.eu/2026/10/26/leeds-ai-spinout-adsilico-raises-ps10m-to-test-medical-devices-on-virtual-patients).
Lead · PXN VenturesExisting investor · Northern Gritstone ✓Existing investor · Parkwalk
On the deal: Duncan Johnson (CEO; spoke for the firm in the announcement, Northern Gritstone)
Announced by the company · northern-gritstone.com ↗On the timeline →
Research entries are the timeline's graded entries that name this company. A level grades one claim, not the company, and a blank can mean the record has not caught up rather than that nothing was published.
On the investors' own sites
Investors that name this company on their own site, in a portfolio or their own announcement. A ✓ in a round marks the same investor.
- Northern Gritstonenorthern-gritstone.com ↗
Its investors also backed
Other companies on this page whose rounds name the same investor.
- Northern GritstoneMatter Machine